Baird Medical Investment Holdings Ltd Warrant (BDMDW) Financials
Newest figures come from the 10-K for FY2025, filed Jul 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BDMDW SEC filings page.
Baird Medical Investment Holdings Ltd Warrant (BDMDW) reported $22.5M in revenue for fiscal year 2025, down 39.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue contraction met an R&D-led cost surge, turning a high-gross-margin model into a heavily loss-making year.
In FY2025, revenue fell39.1% from FY2024 while R&D more than tripled, showing that the expense base expanded despite weaker sales. Gross margin remained elevated at83.8% , yet the company recorded an operating loss of-$25.6M , indicating that operating expenses—not product-level profitability—drove the reversal.
The gap between a net loss of
Working capital is concentrated in customer balances: receivables were
Financial Health Signals
Baird Medical Investment Holdings Ltd Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Baird Medical Investment Holdings Ltd Warrant passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Baird Medical Investment Holdings Ltd Warrant reported a net loss of $27.3M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Baird Medical Investment Holdings Ltd Warrant reported an operating loss of $25.6M against $354K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Baird Medical Investment Holdings Ltd Warrant held $178K in cash against $6.1M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
BDMDW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
BDMDW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q2'2510-Q | Q4'2410-K | Q4'2310-K |
|---|---|---|---|---|
| Total Assets | $69.7M-10.6% | $77.0M | $78.0M+37.5% | $56.7M |
| Current Assets | $55.0M-10.5% | $60.7M | $61.4M+53.2% | $40.1M |
| Cash & Equivalents | $178K-94.0% | $2.2M | $3.0M+96.6% | $1.5M |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Inventory | $1.1M-16.3% | $1.4M | $1.3M+13.5% | $1.1M |
| Accounts Receivable | $42.5M-8.7% | $40.8M | $46.6M+49.8% | $31.1M |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Goodwill | $60K+4.4% | $59K | $58K-2.7% | $59K |
| Total Liabilities | $38.5M+0.7% | $41.4M | $38.2M+81.9% | $21.0M |
| Current Liabilities | $32.4M-6.5% | $35.5M | $34.6M+82.5% | $19.0M |
| Non-Current Liabilities | $6.1M+70.8% | $5.9M | $3.6M+76.7% | $2.0M |
| Long-Term Debt | $6.1M+76.8% | $5.8M | $3.4M+113.3% | $1.6M |
| Total Equity | $31.4M-20.9% | $35.6M | $39.7M+10.9% | $35.8M |
| Retained Earnings | -$515K-101.9% | $15.5M | $26.8M+85.9% | $14.4M |
BDMDW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
BDMDW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Where Baird Medical Investment Holdings Ltd Warrant Ranks
Frequently Asked Questions
What is Baird Medical Investment Holdings Ltd Warrant's annual revenue?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) reported $22.5M in total revenue for fiscal year 2025. This represents a -39.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Baird Medical Investment Holdings Ltd Warrant's revenue growing?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) revenue declined by 39.2% year-over-year, from $37.0M to $22.5M in fiscal year 2025.
Is Baird Medical Investment Holdings Ltd Warrant profitable?
No, Baird Medical Investment Holdings Ltd Warrant (BDMDW) reported a net income of -$27.3M in fiscal year 2025.
What is Baird Medical Investment Holdings Ltd Warrant's EBITDA?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) had EBITDA of -$24.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Baird Medical Investment Holdings Ltd Warrant have?
As of fiscal year 2025, Baird Medical Investment Holdings Ltd Warrant (BDMDW) had $178K in cash and equivalents against $6.1M in long-term debt.
What is Baird Medical Investment Holdings Ltd Warrant's gross margin?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) had a gross margin of 83.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Baird Medical Investment Holdings Ltd Warrant's return on equity (ROE)?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) has a return on equity of -87.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Baird Medical Investment Holdings Ltd Warrant's free cash flow?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) recorded an outflow of $1.4M in free cash flow during fiscal year 2025. This represents a 84.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Baird Medical Investment Holdings Ltd Warrant's operating cash flow?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) recorded an outflow of $1.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Baird Medical Investment Holdings Ltd Warrant's total assets?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) had $69.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Baird Medical Investment Holdings Ltd Warrant's capital expenditures?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) invested $42K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Baird Medical Investment Holdings Ltd Warrant spend on research and development?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) invested $20.1M in research and development during fiscal year 2025.
What is Baird Medical Investment Holdings Ltd Warrant's current ratio?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) had a current ratio of 1.70 as of fiscal year 2025, which is generally considered healthy.
What is Baird Medical Investment Holdings Ltd Warrant's debt-to-equity ratio?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Baird Medical Investment Holdings Ltd Warrant's return on assets (ROA)?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) had a return on assets of -39.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Baird Medical Investment Holdings Ltd Warrant's Piotroski F-Score?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Baird Medical Investment Holdings Ltd Warrant's earnings high quality?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) reported a net loss of $27.3M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Baird Medical Investment Holdings Ltd Warrant cover its interest payments?
Baird Medical Investment Holdings Ltd Warrant (BDMDW) reported an operating loss of $25.6M against $354K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.